Lisa Bouchier‐Hayes

ORCID: 0000-0003-3886-5977
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cell death mechanisms and regulation
  • Virus-based gene therapy research
  • CAR-T cell therapy research
  • Viral Infectious Diseases and Gene Expression in Insects
  • Mitochondrial Function and Pathology
  • Inflammasome and immune disorders
  • Autophagy in Disease and Therapy
  • DNA Repair Mechanisms
  • RNA Interference and Gene Delivery
  • ATP Synthase and ATPases Research
  • Ubiquitin and proteasome pathways
  • Cancer-related Molecular Pathways
  • interferon and immune responses
  • RNA modifications and cancer
  • Acute Myeloid Leukemia Research
  • Endoplasmic Reticulum Stress and Disease
  • S100 Proteins and Annexins
  • Microtubule and mitosis dynamics
  • NF-κB Signaling Pathways
  • Hemoglobinopathies and Related Disorders
  • Heme Oxygenase-1 and Carbon Monoxide
  • Cancer Research and Treatments
  • Immune Response and Inflammation
  • CRISPR and Genetic Engineering
  • Neonatal Respiratory Health Research

Baylor College of Medicine
2015-2024

Texas Children's Hospital
2011-2024

Houston Methodist
2015

Methodist Hospital
2015

St. Jude Children's Research Hospital
2006-2011

La Jolla Institute for Immunology
2004-2006

University of Iowa
2005

Johannes Gutenberg University Mainz
2004

Trinity College Dublin
2000-2003

The tumor suppressor p53 exerts its anti-neoplastic activity primarily through the induction of apoptosis. We found that cytosolic localization endogenous wild-type or trans-activation-deficient was necessary and sufficient for directly activated proapoptotic Bcl-2 protein Bax in absence other proteins to permeabilize mitochondria engage apoptotic program. also released both multidomain BH3-only [Proapoptotic family share only third homology domain (BH3)] were sequestered by Bcl-xL....

10.1126/science.1092734 article EN Science 2004-02-12

The Trp53 tumor suppressor gene product (p53) functions in the nucleus to regulate proapoptotic genes, whereas cytoplasmic p53 directly activates Bcl-2 proteins permeabilize mitochondria and initiate apoptosis. Here, we demonstrate that a tripartite nexus between Bcl-xL, p53, PUMA coordinates these distinct functions. After genotoxic stress, Bcl-xL sequestered p53. Nuclear caused expression of PUMA, which then displaced from allowing induce mitochondrial permeabilization. Mutant bound but...

10.1126/science.1114297 article EN Science 2005-09-08

During apoptosis, the mitochondrial outer membrane is permeabilized, leading to release of cytochrome c that activates downstream caspases. Mitochondrial permeabilization (MOMP) has historically been thought occur synchronously and completely throughout a cell, rapid caspase activation apoptosis. Using new imaging approach, we demonstrate MOMP not an all-or-nothing event. Rather, find minority mitochondria can undergo in stress-regulated manner, phenomenon term "minority MOMP." Crucially,...

10.1016/j.molcel.2015.01.018 article EN cc-by Molecular Cell 2015-02-19

Abstract The clinical efficacy of chimeric antigen receptor (CAR)-redirected T cells remains marginal in solid tumors compared with leukemias. Failures have been attributed to insufficient T-cell migration and the highly immunosuppressive milieu tumors. To overcome these obstacles, we combined CAR-T an oncolytic virus armed chemokine RANTES cytokine IL15, reasoning that modified will both a direct lytic effect on infected malignant facilitate survival cells. Using neuroblastoma as tumor...

10.1158/0008-5472.can-14-0697 article EN Cancer Research 2014-07-25

The mechanisms through which Caspase-2 leads to cell death are controversial. Here we show, using a combination of cell-free and culture-based approaches, that cleavage the Bcl-2-family protein Bid is required for induction apoptosis by Caspase-2. promoted cytochrome c release from mitochondria in presence cytosol wild-type, but not Bid-deficient, mouse embryonic fibroblasts (MEFs). Recombinant wild-type Bid, noncleavable mutant (D59E), restored release. Similarly, Bid-null MEFs were...

10.1091/mbc.e05-12-1107 article EN Molecular Biology of the Cell 2006-02-22

Caspase-2, one of the most evolutionarily conserved caspase family, has been implicated in maintenance chromosomal stability and tumour suppression. Caspase-2 deficient (Casp2−/−) mice develop normally but show premature ageing-related traits when challenged by certain stressors, succumb to enhanced development aneuploidy. To test how caspase-2 protects against instability, we utilized an ex vivo system for aneuploidy where primary splenocytes from Casp2−/− were exposed anti-mitotic drugs...

10.1038/onc.2016.423 article EN cc-by-nc-sa Oncogene 2016-12-19

The PIDDosome (PIDD-RAIDD-caspase-2 complex) is considered to be the primary signaling platform for caspase-2 activation in response genotoxic stress. Yet studies of PIDD-deficient mice show that can proceed absence PIDD. Here we DNA damage induces assembly at least two distinct platforms caspase-2: a cytoplasmic RAIDD dependent but PIDD independent, and nucleolar requires both RAIDD. Furthermore, phosphoprotein nucleophosmin (NPM1) acts as scaffold essential nucleolus after damage....

10.1083/jcb.201608095 article EN cc-by-nc-sa The Journal of Cell Biology 2017-04-21

Proteins possessing the caspase recruitment domain (CARD) motif have been implicated in pathways leading to activation of caspases or NF-κB context apoptosis inflammation, respectively. Here we report identification a novel protein, CARDINAL, that contains CARD and also exhibits high degree homology C terminus DEFCAP/NAC, recently described member Apaf-1/Nod-1 family. In contrast with majority proteins date, CARDINAL failed promote activation. Rather, potently suppressed associated...

10.1074/jbc.m107373200 article EN cc-by Journal of Biological Chemistry 2001-11-01

Tumour necrosis factor (TNF)‐related apoptosis‐inducing ligand (TRAIL) is a member of the TNF family cytokines that promotes apoptosis and NF‐κB activation. Here we show recombinant hu‐TRAIL initiates activation multiple caspases, loss mitochondrial transmembrane potential, cleavage BID redistribution cytochrome c . However, whereas Bcl‐2 efficiently blocked UV radiation‐induced release consequent CEM cells, it failed to do either in context TRAIL treatment. Thus, engages death pathway at...

10.1016/s0014-5793(00)01375-2 article EN FEBS Letters 2000-04-05

Abstract New therapies for glioblastoma (GBM) are needed, as five-year survival is <10%. The proteasome inhibitor marizomib (MRZ) has inhibitory and death-inducing properties unique from previous inhibitors such bortezomib (BTZ) not been well examined in GBM. We evaluated the mechanism of death vivo MRZ activation kinetics initiator caspases 2, 8 9 were assessed using chemical knockdown strategies to determine their contribution cell death. Blood brain barrier permeance inhibition by BTZ...

10.1038/srep18953 article EN cc-by Scientific Reports 2016-01-25
Coming Soon ...